Phase 2 Primary CNS Lymphoma Clinical Trials
5 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–5 of 5 trials
Recruiting
Phase 2
Study of Lenalidomide/Rituximab Maintenance for Transplantation Ineligible Patients With PCNSL.
Primary CNS Lymphoma
Kim, Seok Jin30 enrolled1 locationNCT04627753
Recruiting
Phase 2
Study of Epcoritamab in R/R Primary Diffuse Large B-cell Lymphoma of the CNS Treated With Lenalidomide and Rituximab
Primary CNS Lymphoma (PCNSL)
The Lymphoma Academic Research Organisation60 enrolled13 locationsNCT06931652
Recruiting
Phase 2
Anbalcabtagene Autoleucel in Relapsed/Refractory CNS Lymphoma
Primary CNS Lymphoma (PCNSL)
Hyungwoo Cho12 enrolled1 locationNCT07062627
Recruiting
Phase 2
NB02 (Poseltinib) Combined Rituximab and Lenalidomide in R/R PCNSL
Primary CNS Lymphoma (PCNSL)
NOBO Medicine33 enrolled10 locationsNCT06737250
Recruiting
Phase 2
RL-MPV Followed by BBC HCT Using Autologous Stem Cells and Maintenance Therapy With Nivolumab for Newly Diagnosed PCNSL
Primary CNS Lymphoma
National Research Center for Hematology, Russia30 enrolled1 locationNCT05425654